Targeted drug delivery revolutionizes pharmaceutical interventions by precisely directing therapeutic agents to specific cells or tissues, minimizing side effects and maximizing treatment efficacy. This innovative approach involves the use of nanocarriers, such as liposomes or nanoparticles, engineered to transport drugs directly to the intended target. These nanocarriers are designed to exploit unique features of the target cells, such as overexpressed receptors or specific microenvironments. Through surface modifications and functionalization, these carriers can navigate biological barriers and release the drug payload at the desired location. This precision reduces the dosage required and minimizes systemic exposure, mitigating adverse effects.
Moreover, targeted drug delivery holds immense promise in oncology. By focusing on cancer cells, it enhances the selectivity of chemotherapy, sparing healthy tissues. This approach not only improves treatment outcomes but also elevates the quality of life for patients undergoing therapy. As research in nanotechnology advances, the potential applications of targeted drug delivery extend beyond oncology to various therapeutic areas. Cardiovascular diseases, neurodegenerative disorders, and infectious diseases stand to benefit from this tailored drug delivery strategy.
Targeted drug delivery systems hold the remarkable potential to improve the therapeutic index of diabetes medications. Herein, we developed a targeted delivery platform for type 1 diabetes (T1D)…
Doxorubicin loaded PLGA nanoparticles were prepared and surface functionalization using trastuzumab, for targeted delivery. Nanoformulations were prepared by double emulsion solvent evaporation…
Participants can earn 1 CPD credit for each hour of attendance.
Oral and poster slots for original Targeted drug delivery work, reviewed by the scientific committee.
Meet nanotechnologists, researchers, scientists and engineers from around the world across three days.
In-person and virtual registrations include an electronic copy of the abstract book.
Plenary lectures from leading voices shaping Targeted drug delivery research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Targeted drug delivery track is a dedicated stream within World Nano 2027 covering the latest research, innovation, and best practice in Targeted drug delivery. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Nanotechnology researchers, scientists and engineers, educators and students with an interest in Targeted drug delivery are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee.
Yes. World Nano 2027 is a hybrid conference — attend the Targeted drug delivery track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 18–20, 2027· Hybrid · in-person & virtual
Attend without presenting.
